← Back to Clinical Trials
Recruiting NCT06473896

Effect of Ketalar or Dexmedetomidine on Increased Sensitivity to Pain Following Treatment With Remifentanil

Trial Parameters

Condition Cholecystectomy
Sponsor Assaf-Harofeh Medical Center
Study Type INTERVENTIONAL
Phase N/A
Enrollment 90
Sex ALL
Min Age 18 Years
Max Age 85 Years
Start Date 2024-04-18
Completion 2026-04-30
Interventions
KetalarDexmedetomidine

Brief Summary

Analgesia is one of the pillars of anesthesia. One of the common opiates for pain relief, with a short half-life, is Remifentanil. However, following Remifentanil treatment an increased sensitivity to pain \[hyperalgesia\] appears. The aim of the study is to compare the effects between complementary treatments, like Ketalar and Dexmedetomidine, in preventing increased sensitivity to pain after Remifentanil treatment

Eligibility Criteria

Inclusion Criteria: • Patients who are about to undergo alaparoscopic cholecystectomy under general anesthesia Exclusion Criteria: * Patients with sensitivity to the anesthetic * Patients with chronic pain who are in regular treatment * Urgent surgery * Patients with ischemic heart disease * Patients with known bradycardia * Patients with a pacemaker * Prolonged use of opiates * Kidney/liver function problems

Related Trials